• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, November 18, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

TDP2 Acts as Backup Repair Factor for Bleomycin-Induced DNA Damage

by
November 9, 2026
in Biology
Reading Time: 6 mins read
0
TDP2 Acts as Backup Repair Factor for Bleomycin-Induced DNA Damage

TDP2 Acts as Backup Repair Factor for Bleomycin-Induced DNA Damage

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Knocking out tyrosyl-DNA phosphodiesterase 2 in human TK6 lymphoblast cells lacking tyrosyl-DNA phosphodiesterase 1 causes a pronounced delay in the repair kinetics of DNA double-strand breaks induced by the radiomimetic drug bleomycin, establishing a specialized backup repair function that does not operate following exposure to ionizing radiation. A research team investigated these distinct cellular responses by systematically evaluating a panel of nineteen isogenic DNA repair-deficient human cell mutants against both physical X-rays and chemical bleomycin treatments. The investigation demonstrated that while cellular non-homologous end joining and homologous recombination pathways both participate in repairing double-strand breaks produced by both damaging agents, the tyrosyl-DNA phosphodiesterase pathway exhibits a divergent contribution depending on the specific source of damage. Whereas cells deficient in tyrosyl-DNA phosphodiesterase 1 or 2 display negligible sensitivity changes after X-ray irradiation, double-deficient cells exhibit heightened sensitivity and prolonged repair deficiency exclusively following treatment with bleomycin.

Bleomycin is a glycopeptide clinical agent that exhibits potent antitumor activity against lymphomas, malignant germ cell tumors, and carcinomas of the skin, head, and neck. The compound generates free radicals in DNA, which results in double-strand breaks alongside single-strand breaks in an observed ratio of approximately one to six to one to twenty. Because exposure to ionizing radiation causes double-strand breaks and single-strand breaks at an approximate ratio of one to twenty through free radical generation, bleomycin is classified as a radiomimetic drug. However, clinical and experimental evidence in head and neck squamous cell lines indicates that sensitivity to bleomycin does not necessarily correlate with radiation sensitivity, suggesting that different repair mechanisms respond to the lesions created by each modality. Ionizing radiation deposits energy directly into molecules to disrupt covalent bonds, producing broad lesion spectra encompassing base modifications, strand breaks, and DNA-protein crosslinks throughout the genome.

In contrast to radiation, bleomycin becomes biologically active only upon binding iron(II), followed by oxygen binding and reduction by a cellular reductant. This activated form induces double-strand breaks bearing characteristic three-prime phosphoglycolate and five-prime phosphate terminal ends, while simultaneously generating four-prime oxidized abasic sites where nucleotide bases are lost and the deoxyribose backbone is altered. These distinct structural lesions disrupt essential cellular processes including replication and transcription. Eukaryotic cells employ two primary double-strand break repair pathways to prevent cell death: homologous recombination and non-homologous end joining. Homologous recombination involves nucleolytic end resection at break sites, homology searching, strand invasion into a homologous template facilitated by RAD54, and template-directed repair synthesis. Non-homologous end joining rejoins broken DNA ends directly without requiring sequence homology, a process initiated by the Ku heterodimer that activates the DNA-dependent protein kinase catalytic subunit and recruits DNA ligase 4, with 53BP1 promoting end joining during the G1 cell-cycle phase.

DNA base damage is converted into single-strand nicks during repair, triggering poly(ADP-ribose) polymerase 1 to undergo self-modification and poly(ADP-ribosyl)ate nearby proteins before interacting with XRCC1 to recruit DNA polymerase beta for gap-filling synthesis and five-prime blocking group excision. Furthermore, crosslink repair mediated by the metalloprotease SPRTN and the proteasome processes DNA-protein adducts, although SPRTN-deficient cells do not exhibit sensitivity to ionizing radiation. To examine how individual repair factors manage physical versus chemical breaks, the study employed an established panel of nineteen isogenic human TK6 lymphoblast mutants. TK6 cells feature rapid proliferation with a thirteen-hour cell cycle and carry functional p53 comparable to normal human tissues. This panel had previously verified repair contributions under normoxic and hypoxic irradiation and established that tyrosyl-DNA phosphodiesterase pathways dominate the repair of lesions produced by camptothecin, providing a defined system to dissect how repair factors respond to bleomycin exposure.

For survival assays, TK6 cells were grown in RPMI-1640 medium supplemented with heat-inactivated horse serum, sodium pyruvate, penicillin, streptomycin, and L-glutamine at thirty-seven degrees Celsius under five percent carbon dioxide. Cultures were either exposed to X-rays from an OHMic OM-303 M generator operating at seventy kilovolts and three milliamperes with an aluminum filter or incubated with bleomycin sulfate for three hours. The treated cells were seeded in triplicate into six-well plates containing methylcellulose medium supplemented with ten percent horse serum, and surviving colonies were counted between days ten and fourteen to calculate the lethal dose yielding ten percent survival, designated as LD10. To assess physical break rejoining directly, the team performed neutral comet assays. Cells exposed to twenty Gray of X-rays or four hundred micrograms per milliliter of bleomycin for thirty minutes were allowed to repair in drug-free medium for one hundred and eighty minutes before automated scoring of tail moments across fifty cells per sample.

Systematic survival profiling of the nineteen mutant lines revealed that non-homologous end joining is the dominant pathway required for cellular survival following bleomycin exposure. Strains lacking LIG4, DNA-PKcs, or 53BP1 exhibited pronounced hypersensitivity to both bleomycin and X-rays. Conversely, homologous recombination-deficient cells demonstrated profound hypersensitivity to X-rays but only minimal sensitivity to bleomycin, indicating that while homologous recombination and non-homologous end joining contribute equally to repairing radiation damage, non-homologous end joining bears primary responsibility for resolving bleomycin lesions. Cells harboring simultaneous deletions of RAD54 and LIG4 displayed greater sensitivity to both agents than either single-mutant line, demonstrating that double-strand breaks constitute the primary lethal lesion generated by both physical radiation and the radiomimetic compound. However, when the authors evaluated cell lines deficient in tyrosyl-DNA phosphodiesterases, they identified a clear functional separation between the damage responses elicited by the two agents.

Cells deficient in tyrosyl-DNA phosphodiesterase 1 displayed marked sensitivity to bleomycin but little sensitivity to X-rays, whereas double-knockout cells lacking both tyrosyl-DNA phosphodiesterase 1 and tyrosyl-DNA phosphodiesterase 2 showed substantially greater sensitivity to bleomycin than single mutants, without any enhanced sensitivity to X-rays. This specific sensitivity pattern mirrors that observed with camptothecin, which traps topoisomerase 1 cleavage complexes repaired primarily by tyrosyl-DNA phosphodiesterase 1, with tyrosyl-DNA phosphodiesterase 2 functioning as an enzymatic backup. In tyrosyl-DNA phosphodiesterase 2, the critical Glu152 residue binds and stabilizes catalytic magnesium ions required to resolve trapped topoisomerase cleavage complexes. To evaluate whether this catalytic coordination is similarly required for repairing bleomycin damage, the researchers tested cells bearing a biallelic Glu152Gln mutation in tyrosyl-DNA phosphodiesterase 2. In tyrosyl-DNA phosphodiesterase 1-deficient cells, introducing this mutation significantly increased sensitivity to bleomycin, whereas sensitivity to X-rays remained unaltered, confirming that magnesium binding to tyrosyl-DNA phosphodiesterase 2 is vital for processing bleomycin lesions.

To assess whether these survival patterns corresponded to direct differences in double-strand break repair kinetics, the authors performed neutral comet assays following physical radiation. Wild-type cells, single-knockout lines, double-knockout cells, and Glu152Gln mutant lines were exposed to twenty Gray of X-rays and allowed to recover in drug-free medium for one hundred and eighty minutes. Automated analysis measured tail moments across fifty cells per sample across three independent experimental trials. Because individual mutant cell lines exhibited baseline variations in initial tail moments immediately after irradiation, median tail moment values were standardized relative to values measured at zero minutes of repair. At one hundred and eighty minutes post-irradiation, statistical analysis using analysis of variance demonstrated that the percentage of remaining double-strand breaks was comparable among wild-type, single-mutant, and double-mutant cells, with p-values exceeding point zero zero five. These kinetic measurements confirmed that neither tyrosyl-DNA phosphodiesterase 1 nor tyrosyl-DNA phosphodiesterase 2 participates meaningfully in resolving X-ray-induced double-strand breaks.

In stark contrast, neutral comet assays evaluating cells treated with four hundred micrograms per milliliter of bleomycin revealed significant kinetic divergence among the mutant lines. Following standardized quantification at one hundred and eighty minutes post-treatment, analysis of variance demonstrated significant differences in remaining double-strand breaks among wild-type, single-knockout, and double-mutant cell lines, with statistical significance meeting p less than point zero zero five. Student’s t-test comparisons demonstrated that double-knockout cells lacking both tyrosyl-DNA phosphodiesterase 1 and 2 suffered a significant delay in break repair kinetics compared to single mutants lacking only tyrosyl-DNA phosphodiesterase 1. Furthermore, cells carrying the Glu152Gln mutation in tyrosyl-DNA phosphodiesterase 2 alongside tyrosyl-DNA phosphodiesterase 1 deletion exhibited an equivalent, statistically significant repair delay relative to single mutants. These direct physical measurements proved that tyrosyl-DNA phosphodiesterase 1 participates in repairing bleomycin-induced double-strand breaks, while tyrosyl-DNA phosphodiesterase 2 serves as an essential backup repair factor requiring its intact Glu152 magnesium-binding residue.

To determine whether tyrosyl-DNA phosphodiesterase 2 processes three-prime phosphoglycolate ends directly, the researchers conducted in vitro biochemical assays using phosphorus-32-labeled single-stranded oligonucleotide substrates and recombinant enzymes resolved by denaturing polyacrylamide gel electrophoresis. While recombinant tyrosyl-DNA phosphodiesterase 1 removed terminal phosphoglycolate groups in optimized buffer, tyrosyl-DNA phosphodiesterase 2 displayed no detectable cleavage activity under identical conditions or across buffers supplemented with magnesium. Because direct cellular labeling of bleomycin-induced phosphoglycolate is currently unfeasible, several mechanistic explanations exist: tyrosyl-DNA phosphodiesterase 2 may resolve alternate minor lesions such as bleomycin-induced DNA-protein crosslinks, may require unoptimized metal or pH conditions, or may depend on cellular chaperones. Elucidating this backup pathway suggests that combining radiomimetic chemotherapy with phosphodiesterase inhibitors presents a potential cancer strategy, though clinical application must overcome challenges including off-target toxicity, emergence of resistance through alternative repair pathways, and the necessity of validating predictive biomarkers.

Subject of Research: DNA double-strand break repair mechanisms under bleomycin exposure in human cells

Article Title: Role of TDP2 in the repair of DNA damage induced by the radiomimetic drug Bleomycin

Article References: Shimizu, N., Izawa, K., Washif, M., Morozumi, R., Hirota, K., & Tsuda, M. (2025). Role of TDP2 in the repair of DNA damage induced by the radiomimetic drug Bleomycin. Genes and Environment, 47(1), Article 7. https://doi.org/10.1186/s41021-025-00329-9

Image Credits: AI Generated

DOI: 10.1186/s41021-025-00329-9

Keywords: Bleomycin, TDP2, TDP1, DNA repair, double-strand breaks, TK6 cells, radiomimetic drugs, non-homologous end joining, Role, repair, damage, induced

News Source: Drew Townsend. (November 9, 2026). TDP2 Acts as Backup Repair Factor for Bleomycin-Induced DNA Damage. Scienmag.

Tags: bleomycindamageDNA Repairdouble-strand breaksinducednon-homologous end joiningradiomimetic drugsrepairroleTDP1TDP2TK6 cells
Share12Tweet7Share2ShareShareShare1

Related Posts

GABA Treatment Associated With Modulated Drought Responses in Contrasting Flax Varieties

GABA Treatment Associated With Modulated Drought Responses in Contrasting Flax Varieties

November 18, 2026
Urban Biodiversity Plans Systematically Exclude Marginalized Populations and Genuine Decision-Making Power

Urban Biodiversity Plans Systematically Exclude Marginalized Populations and Genuine Decision-Making Power

November 18, 2026

Definitive Records Confirm Giant Ruby Snapper Range in Japan and Taiwan

November 18, 2026

Chemical Screening Detects Psilocybin in Seven Chinese Psilocybe Specimens Across Genera

November 18, 2026

POPULAR NEWS

  • Electroacupuncture Mobilizes Unique CD34-Positive Stem-Like Cells in Healthy Dogs

    Electroacupuncture Mobilizes Unique CD34-Positive Stem-Like Cells in Healthy Dogs

    29 shares
    Share 12 Tweet 7
  • Specialists Outline Cervical Cancer Screening Principles for Resource-Limited Settings

    29 shares
    Share 12 Tweet 7
  • Modified Halpern Proximal Algorithm Solves Multi-Structured Problems in Curved Hadamard Spaces

    29 shares
    Share 12 Tweet 7
  • Machine Learning Outperforms Pharmacokinetic Models Predicting Initial Vancomycin Concentrations in Septic Patients

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Surgeons Perform Hybrid Thoracoscopic and Endoscopic Enucleation for Rare Esophageal Foregut Cyst

Vine Tea Transcriptome Analysis Identifies Key Regulators of High Dihydromyricetin Biosynthesis

Carbapenem-Resistant Klebsiella Infections Surge 72 Percent Across Europe Since 2019

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 88 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.